Key Takeaways
- Three senior Oklo executives dumped approximately $21 million worth of company shares on April 1 through pre-scheduled trading arrangements.
- CEO Jacob DeWitte has orchestrated a series of stock sales beginning in January, unloading shares at prices ranging from approximately $100 down to roughly $50.
- CNBC’s Jim Cramer expressed skepticism about Oklo’s commercial viability, stating the company has minimal prospects for profitability in the foreseeable future.
- The nuclear energy startup’s recent quarterly results fell short of Wall Street expectations, posting a loss of $0.27 per share versus the anticipated -$0.17.
- Wall Street maintains a generally optimistic outlook with a “Moderate Buy” consensus and an $84.30 average price target, though multiple analysts have recently reduced their projections.
On April 1, 2026, three senior leaders at Oklo executed stock sales exceeding $21 million in aggregate value, with all transactions conducted through previously established Rule 10b5-1 trading arrangements.
Chief Executive Jacob DeWitte liquidated shares at weighted average transaction prices spanning $48.41 to $51.20, generating proceeds of $10,069,852. Following these dispositions, DeWitte maintains direct ownership of 691,533 Class A shares while controlling more than 20 million additional shares through indirect arrangements.
Chief Operating Officer and company co-founder Caroline Cochran similarly divested holdings worth $10,069,852, with transaction prices distributed between approximately $47.99 and $51.79 per share. Post-sale, Cochran retains direct ownership of 658,039 shares.
Chief Financial Officer Richard Bealmear disposed of 16,342 shares at $51.08 each, realizing $834,749 in proceeds. Bealmear continues to hold 386,008 Class A shares directly.
Each of these transactions was executed under 10b5-1 trading plans, pre-established mechanisms designed to shield executives from potential allegations of trading based on material non-public information.
However, the April 1 dispositions represent merely one chapter in a continuing divestiture narrative for DeWitte. The CEO has methodically sold Oklo shares throughout the period beginning in January, with transactions executed at price points including approximately $112, $75, and $63 per share. Collectively, DeWitte has realized tens of millions in gross proceeds through these systematic sales across recent months.
The April 1 transaction alone — encompassing 200,000 shares distributed across two separate sales — constituted a 17.58% reduction in his direct shareholdings.
Wall Street Commentator Voices Skepticism
The executive stock sales coincide with notably critical remarks from CNBC personality Jim Cramer. When questioned about Oklo during a recent program appearance, Cramer offered an unvarnished assessment: “Oklo, while not a science project, has very little prospects for making any money any time in the future that we think is important for a stock.”
Cramer had previously articulated comparable concerns in January, characterizing Oklo as “not a commercial enterprise” and contending that despite nuclear power’s promising outlook, established operators like GE Vernova — with functioning commercial operations — represent superior investment opportunities compared to Oklo at present.
Financial Performance Falls Short and Price Target Adjustments
From a fundamental perspective, Oklo disclosed a per-share loss of $0.27 for its latest quarterly period, falling short of the consensus projection of -$0.17 by $0.10.
While analyst sentiment remains predominantly constructive, price objectives have undergone downward revisions. UBS reduced its target from $95 to $60 while assigning a neutral rating. Needham lowered its projection from $135 to $73, and Canaccord adjusted downward from $175 to $125. Cantor Fitzgerald maintained its overweight stance with a $122 price objective.
The mean analyst price target presently stands at $84.30, accompanied by a consensus recommendation of “Moderate Buy.” The analyst community breakdown includes two Strong Buy ratings, nine Buy ratings, six Hold ratings, and two Sell ratings.
Oklo’s shares have traded within a 12-month band of $17.42 to $193.84, with the 50-day simple moving average positioned at $64.62 and the 200-day moving average at $93.16.
